Literature DB >> 3663450

Jejunal and ileal absorption of oxprenolol in man: influence of nutrients and digestive secretions on jejunal absorption and systemic availability.

J Godbillon1, N Vidon, R Palma, A Pfeiffer, C Franchisseur, M Bovet, G Gosset, J J Bernier, J Hirtz.   

Abstract

1 Study I evaluated the absorption of oxprenolol in the ileum, compared to jejunum, in healthy volunteers by an intestinal perfusion technique. Around 80 mg of drug were delivered as a saline solution directly in the small bowel. 2 Samples taken 30 cm distally to the site of perfusion showed that 63% of perfused oxprenolol was absorbed in the jejunum and 48% in the ileum; the differences were significant. 3 The plasma concentration-time profiles were similar for the two perfusions. The AUC and Cmax values of free and conjugated oxprenolol for the jejunal perfusion were significantly lower than those of ileum. They showed large but consistent intersubject variations in the two treatments. 4 Study II investigated, using the same technique, the influence of nutrients and digestive secretions on jejunal absorption and systemic availability of this drug. A saline (in treatments A and B) or a nutrient (in treatment C) solution containing oxprenolol was perfused into the jejunum below a balloon either inflated (A) or deflated (B and C). 5 The disappearance rate of oxprenolol from the jejunum was unaffected by endogenous secretions. The mean amount of drug absorbed along a 30-cm jejunal segment accounted for 52 (A) and 57% (B) of the total amount perfused. The intestinal absorption rate was markedly increased in the presence of nutrients (mean amount absorbed 96% for C). 6 The change in the rate of disappearance from the intestine had no effect on the systemic availability of oxprenolol (mean AUC values 8740, 8250 and 8020 nmol l-1 h for A, B and C, respectively) or its elimination from plasma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663450      PMCID: PMC1386255          DOI: 10.1111/j.1365-2125.1987.tb03178.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Pharmacokinetics of oxprenolol in normal subjects.

Authors:  W D Mason; N Winer
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

Review 2.  The method of intraluminal perfusion of the human small intestine. I. Principle and technique.

Authors:  R Modigliani; J C Rambaud; J J Bernier
Journal:  Digestion       Date:  1973       Impact factor: 3.216

3.  Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption.

Authors:  D Evard; N Vidon; J Godbillon; M Bovet; M Duval; J P Schoeller; J J Bernier; J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

4.  Influence of food intake on plasma oxprenolol concentrations following oral administration of conventional and Oros preparations.

Authors:  V A John; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Determination of oxprenolol in human plasma by high-performance liquid chromatography, in comparison with gas chromatography and gas chromatography-mass spectrometry.

Authors:  J Godbillon; M Duval; G Gosset
Journal:  J Chromatogr       Date:  1985-12-13

6.  Bioavailability of conventional and slow-release oxprenolol in fasted and nonfasted individuals.

Authors:  C P Dawes; M J Kendall; P G Welling
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

7.  Gastric and intestinal absorption of oxprenolol in humans.

Authors:  N Vidon; R Palma; J Godbillon; C Franchisseur; G Gosset; J J Bernier; J Hirtz
Journal:  J Clin Pharmacol       Date:  1986 Nov-Dec       Impact factor: 3.126

8.  Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration.

Authors:  F Theeuwes; D R Swanson; G Guittard; A Ayer; S Khanna
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

9.  Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing.

Authors:  K H Antonin; P Bieck; M Scheurlen; M Jedrychowski; H Malchow
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

10.  Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum.

Authors:  N Vidon; D Evard; J Godbillon; M Rongier; M Duval; J P Schoeller; J J Bernier; J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

  10 in total
  1 in total

1.  Almitrine bismesylate disposition in the human digestive tract.

Authors:  N Vidon; S Chaussade; J P Jeanniot; B Huchet; C Franchisseur; J J Bernier
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.